|
|
| Line 1: |
Line 1: |
| __NOTOC__ | | __NOTOC__ |
|
| |
|
| {| class="wikitable"
| |
| ! colspan="5" |Salvage therapies for Helicobacter pylori infection
| |
| |-
| |
| |Regimen
| |
| |Drugs(doses)
| |
| |Dosing frequency
| |
| |Duration(days)
| |
| |FDA approval
| |
| |-
| |
| |Bismuth quadruple
| |
| |
| |
| * PPI(standard dose)
| |
| * Bismuth subciitrate(120-300mg or sub salicylate(300mg)
| |
| * Tetracycline(500mg)
| |
| * Metronidazole(500mg)
| |
| |BID
| |
|
| |
| QID
| |
|
| |
| QID
| |
|
| |
| TID or QID
| |
| |14
| |
| |NO<sup>(a)</sup>
| |
| |-
| |
| |Levofloxacin triple
| |
| |
| |
| * PPI(standard dose)
| |
| * Levofloxacin (500mg)
| |
| * Amoxicillin(1gm)
| |
| |BID
| |
|
| |
| QD
| |
|
| |
| BID
| |
| |14
| |
| |NO
| |
| |-
| |
| |Concomitant
| |
| |
| |
| * PPI(standard dose)
| |
| * Clarithromycin(500mg)
| |
| * Amoxicillin(1gm)
| |
| * Nitroimidazole(500mg)
| |
| |BID
| |
|
| |
| BID
| |
|
| |
| BID
| |
|
| |
| BID or TID
| |
| |10-14
| |
| |NO
| |
| |-
| |
| |Rifabutin triple
| |
| |
| |
| * PPI(standard dose)
| |
| * Rifabutin(300mg)
| |
| * Amoxicillin(1gm)
| |
| |BID
| |
|
| |
| QD
| |
|
| |
| BID
| |
| |10
| |
| |NO
| |
| |-
| |
| |High-dose dual
| |
| |
| |
| * PPI(standard to double dose)
| |
| * Amoxicillin(1gm TID or 750mg QID)
| |
| |TID or QID
| |
|
| |
| TID or QID
| |
| |14
| |
| |NO
| |
| |}
| |
| (a)PPI,Bismuth,tetracyclin and metronidazole prescribed separately is not an FDA-approved treatment regimen.However,Pylera,a combination product containing bimuth subcitrate,tetracyclin and metronidazole combined with a PPI for 10 days is an FDA-approved treatment regimen
| |
|
| |
|
| {{CMG}}; {{AE}} {{MKK}} | | {{CMG}}; {{AE}} {{MKK}} |
| | | {| |
|
| |
|
| ==References== | | ==References== |
Revision as of 16:25, 20 November 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
References
- References should be cited for the material that you have put on your page. Type in {{reflist|2}}.This will generate your references in small font, in two columns, with links to the original article and abstract.
- For information on how to add references into your page, click here.